Navigation Links
Treating Kidneys With Radio Waves May Ease Tough-to-Control Hypertension
Date:12/17/2012

By Steven Reinberg
HealthDay Reporter

MONDAY, Dec. 17 (HealthDay News) -- For patients whose high blood pressure cannot be controlled despite taking several medications, a short burst of radio waves at the nerves around the kidneys may do the trick, a small new study says.

The treatment was effective for at least six months. The findings could be a significant step in treating people with resistant hypertension, which is a major risk factor for heart attack and stroke, the researchers said.

The technique -- called catheter-based renal denervation -- is minimally invasive. In it, doctors use a catheter inserted through the artery in the groin, which sends radio waves burning away nerve tissue around the arteries that feed the kidneys.

The procedure destroys nerves that help control and filter salt in the body and may be overactive in patients with high blood pressure. The U.S. Food and Drug Administration has not yet approved its use.

The study was funded by medical device maker Medtronic. The findings were published Dec. 17 in the journal Circulation.

"This is a very promising approach for managing medication-resistant hypertension," said Dr. Gregg Fonarow, a spokesman for the American Heart Association and professor of cardiology at the University of California, Los Angeles.

"High blood pressure is a major contributor to heart attack, stroke, heart failure, and [kidney] failure," said Fonarow, who was not involved in the study. "Despite the availability of a number of effective medications, many patients with hypertension have not achieved adequate control of their blood pressure. There is thus an important, but currently unmet, need for additional therapies to effectively control hypertension."

For the study, an international team lead by Dr. Murray Esler, professor and senior director of the Baker IDI Heart and Diabetes Institute in Melbourne, Australia, assigned 35 patients to renal denervation and compared them to 47 patients who had already had the procedure.

All the patients suffered from drug-resistant hypertension. Their systolic blood pressure -- the top number in a blood-pressure reading -- remained dangerously high at 160 millimeters of mercury (mmHg) or above despite having taking three or more drugs to control blood pressure, the researchers noted.

Esler's team found that more than 83 percent of those who had denervation treatment before had a drop in systolic blood pressure of at least 10 mmHg after six months and almost 79 percent maintained the reduction at 12 months.

The 35 patients in this phase of the study had similar results to the initial group. Almost 63 percent of these patients saw a reduction in systolic blood pressure of 10 mmHg or more six months after treatment.

Fonarow noted: "In all, reductions in systolic blood-pressure levels on the order of 25 to 30 mmHg were achieved and maintained without any loss in efficacy."

The procedure is safe as well as effective, the study authors said.

"Participants' kidneys were not damaged or functionally impaired," Esler said in a journal news release. "We also found no ill effects on long-term health from the procedure."

Whether this technique might be useful in treating less severe high blood pressure hasn't yet been tested. If it is applicable, it could mean patients need not take blood-pressure drugs, Esler suggested.

Another expert, however, said that scenario is likely overoptimistic.

"Hypertension is a hard disease to treat because there are so many things that go into getting blood pressure under control," said Dr. Varinder Singh, an interventional cardiologist at Lenox Hill Hospital in New York City. "There's lifestyle and diet, there is getting to the right doses of medications, there are adherence issues. So anything that will help patients get their goals is exciting."

Even with this technique, people will most likely still have to take blood-pressure medications, Singh said. "You may have to take less medication and you may have to take lower doses of medication, but we all expect that patients will still have to take some medication," he said.

Singh also noted that although this procedure is used in other countries it is not yet approved in the United States.

Fonarow added: "While this study demonstrates that renal denervation provides sustained reduction of blood pressure up to one year and appears safe, additional studies with longer-term follow-up are needed."

According to the American Heart Association, more than 78 million adults in the United States have high blood pressure, which is blood pressure higher than 140/90 mmHg.

Among these adults, about 9 percent have resistant hypertension, which means that even taking three or more medications to control their blood pressure, it remains higher than 140/90 mmHg.

More information

To learn more about hypertension, visit the U.S. National Library of Medicine.

SOURCES: Gregg Fonarow, M.D., spokesman, American Heart Association, and professor of cardiology, University of California, Los Angeles; Varinder Singh, M.D., interventional cardiologist, Lenox Hill Hospital, New York City; American Heart Association news release; Dec. 17, 2012, Circulation


'/>"/>
Copyright©2012 ScoutNews,LLC.
All rights reserved

Related medicine news :

1. Study Suggests Treating Dyslexia Before Kids Learn to Read
2. New standards for treating traumatic shoulder injuries to improve patient care
3. Treating childhood obesity: A family affair
4. Unique physiology key to diagnosing and treating diabetes in Asian populations
5. Studies See Advances in Detecting, Treating Pancreatic Cancer
6. 1 size doesnt fit all when treating blood pressure in people with diabetes, VA/U-M study suggests
7. Nanomedicines promise fewer side effects in treating cancer
8. Mount Sinai researchers develop a multi-target approach to treating tumors
9. A non-antibiotic approach for treating urinary tract infections
10. UT Southwestern study shows treating diabetes early, intensively is best strategy
11. Researchers report success in treating autism spectrum disorder
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/27/2016)... ... May 27, 2016 , ... ... in the pharmaceutical, medical and food industries. Aside from its GMP accreditation, Validation ... providing proof of successfully certified products, services and staff. , Validation Center is ...
(Date:5/26/2016)... ... 26, 2016 , ... Intalere, the healthcare industry leader in ... inaugural Member Conference at the Paris Hotel in Las Vegas, Nev., May 17-20, ... America’s healthcare providers. , The conference was highlighted by the announcement of the ...
(Date:5/26/2016)... ... May 26, 2016 , ... Cardiac arrhythmia ... negative impact on long-term patient survival, reports a team of UPMC researchers in ... week in the Journal of Thoracic and Cardiovascular Surgery, provide critical information that ...
(Date:5/26/2016)... (PRWEB) , ... May 26, 2016 , ... An April ... American families. , The 550 employees of Sun Health Senior Living (SHSL) ... Aetna that reduces their doctor and prescription copays for the year, while holding the ...
(Date:5/26/2016)... ... May 26, 2016 , ... The Lung Institute ... a six-week smoking cessation class starting June 6 at their clinic in downtown Tampa. ... . , Additionally, the Lung Institute has created a free downloadable 4 Week ...
Breaking Medicine News(10 mins):
(Date:5/25/2016)... , May 25, 2016 ... H1 2016"market research report that provides an overview ... comparative analysis at various stages, therapeutics assessment by ... administration (RoA) and molecule type, along with latest ... also reviews key players involved in the therapeutic ...
(Date:5/24/2016)... Cirujanos holandeses han puesto en ... médicos a compartir sus mejores prácticas por el mundo ... médicos de Europa, África, Asia ... aplicación, que combina la transmisión en vivo con mensajería ... Educación   "Imagine un médico de Medicines ...
(Date:5/24/2016)... 24, 2016   , ... in overall bowel cleansing and superiority in ... leansing of the ascending ... , Norgine B.V. today announced new positive data from ... ascorbate bowel preparation) versus standard 2 litre PEG with ascorbate. The ...
Breaking Medicine Technology: